Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-13

Clinical Trial Update: Thalidomide in the Treatment of Chronic Plaque Psoriasis. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of thalidomide in chronic plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thalidomide (thalidomide)

Snippet

Sponsor: Wake Forest University | Conditions: Psoriasis, Plaque-type | Phase 2 | Status: COMPLETED